Who Supplies Roxithromycin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Roxithromycin exports, with 78+ registered manufacturers shipping to buyers across 30+ countries — yet a handful of companies dominate the shipments. BRAWN LABORATORIES LIMITED holds the largest share at 26.3% (export value: $1.1M). Close behind, STRIDES PHARMA SCIENCE LIMITED (10.5%, $438.9K). MARKSANS PHARMA LIMITED (9.8%, $408.9K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Roxithromycin? Top Manufacturers & Their Buyers
Flow of Roxithromycin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Roxithromycin Supplier Network — Key Market Intelligence
The Roxithromycin export market from India is led by BRAWN LABORATORIES LIMITED, which alone commands a 26.3% share, shipping $1.1M worth of product across 14 shipments. The second-largest exporter, STRIDES PHARMA SCIENCE LIMITED, contributes $438.9K (10.5%) to the overall market. Combined, the top two suppliers alone account for 36.8% of all Roxithromycin exports, indicating a relatively concentrated supply base.
Across all 78 tracked manufacturers, the total Roxithromycin export value stands at $4.2M from 427 shipments. The market average shipment value is $9.8K. The single largest buyer relationship in terms of trade value is MILITARY COMMERICAL JOINT STOCK BANK, receiving $590.8K worth of product.
The combined buyer network spans 15 named purchasing companies, including MILITARY COMMERICAL JOINT STOCK BANK, MILITARY COMMERCIAL , GRACE WIN COMPANY LI, ADVANCED BANK OF ASI, ARROW PHARMACEUTICALS PTY LTD and 10 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1BRAWN LABORATORIES LIMITED
BRAWN LABORATORIES LIMITED is the first-largest Roxithromycin exporter from India, with a market share of 26.3% and a total export value of $1.1M across 14 shipments. Their average shipment value of $78.3K is above the market average of $9.8K, suggesting premium or bulk contract pricing.
BRAWN LABORATORIES LIMITED serves 5 named buyers in our database. MILITARY COMMERICAL JOINT STOCK BANK is the dominant customer, accounting for 53.9% of this supplier's tracked business. Top customers include:
• MILITARY COMMERICAL JOINT STOCK BANK — $590.8K across 8 shipments (53.9% of this supplier's total exports)
• MILITARY COMMERICAL JOINT STOCK BANK — $295.6K across 4 shipments (27.0% of this supplier's total exports)
• MILITARY COMMERCIAL — $160.5K across 2 shipments (14.6% of this supplier's total exports)
• GRACE WIN COMPANY LI — $32.8K across 0 shipments (3.0% of this supplier's total exports)
• ADVANCED BANK OF ASI — $16.4K across 0 shipments (1.5% of this supplier's total exports)
Key Insight: BRAWN LABORATORIES LIMITED's per-shipment value of $78.3K is 701% above the market average of $9.8K, consistent with large-order contracts or value-added formulations.
2STRIDES PHARMA SCIENCE LIMITED
STRIDES PHARMA SCIENCE LIMITED is the second-largest Roxithromycin exporter from India, with a market share of 10.5% and a total export value of $438.9K across 54 shipments. Their average shipment value of $8.1K is below the market average of $9.8K, reflecting a high-volume, competitive pricing strategy.
STRIDES PHARMA SCIENCE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ARROW PHARMACEUTICALS PTY LTD — $150.2K across 18 shipments (34.2% of this supplier's total exports)
• APOTEX PTY LTD., — $96.9K across 12 shipments (22.1% of this supplier's total exports)
• APOTEX PTY LIMITED — $77.0K across 9 shipments (17.5% of this supplier's total exports)
• ARROW PHARMACEUTICALS PTY LTD — $62.0K across 8 shipments (14.1% of this supplier's total exports)
• APOTEX PTY LTD., — $52.8K across 6 shipments (12.0% of this supplier's total exports)
Key Insight: STRIDES PHARMA SCIENCE LIMITED operates with high shipment frequency (54 shipments) at a per-shipment value of $8.1K, indicating a broad distribution network with many smaller, regular orders.
3MARKSANS PHARMA LIMITED
MARKSANS PHARMA LIMITED is the third-largest Roxithromycin exporter from India, with a market share of 9.8% and a total export value of $408.9K across 15 shipments. Their average shipment value of $27.3K is above the market average of $9.8K, suggesting premium or bulk contract pricing.
MARKSANS PHARMA LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TEVA PHARMA NEW ZEALAND LIMITED — $170.2K across 6 shipments (41.6% of this supplier's total exports)
• TEVA PHARMA NEW ZEALAND LIMITED — $128.3K across 5 shipments (31.4% of this supplier's total exports)
• ISKP PHARMA CO., LTD — $82.6K across 3 shipments (20.2% of this supplier's total exports)
• ISKP PHARMA CO., LTD — $27.8K across 1 shipments (6.8% of this supplier's total exports)
Key Insight: MARKSANS PHARMA LIMITED's per-shipment value of $27.3K is 179% above the market average of $9.8K, consistent with large-order contracts or value-added formulations.
4TORRENT PHARMACEUTICALS LTD
TORRENT PHARMACEUTICALS LTD is the fourth-largest Roxithromycin exporter from India, with a market share of 4.6% and a total export value of $191.6K across 14 shipments. Their average shipment value of $13.7K is above the market average of $9.8K, suggesting premium or bulk contract pricing.
TORRENT PHARMACEUTICALS LTD serves 3 named buyers in our database. HEUMANN PHARMA GMBH CO. GENERICA KG is the dominant customer, accounting for 83.4% of this supplier's tracked business. Top customers include:
• HEUMANN PHARMA GMBH CO. GENERICA KG — $159.7K across 12 shipments (83.4% of this supplier's total exports)
• HEUMANN PHARMA GMBH CO. GENERICA KG — $26.1K across 2 shipments (13.6% of this supplier's total exports)
• HEUMANN PHARMA GMBH CO. GENERICA KG — $5.7K across 0 shipments (3.0% of this supplier's total exports)
Key Insight: TORRENT PHARMACEUTICALS LTD's per-shipment value of $13.7K is 40% above the market average of $9.8K, consistent with large-order contracts or value-added formulations.
5MICRO LABS LIMITED
MICRO LABS LIMITED is the fifth-largest Roxithromycin exporter from India, with a market share of 1.2% and a total export value of $52.1K across 7 shipments. Their average shipment value of $7.4K is below the market average of $9.8K, reflecting a high-volume, competitive pricing strategy.
MICRO LABS LIMITED serves 2 named buyers in our database. PPS INTERNATIONAL CO is the dominant customer, accounting for 52.0% of this supplier's tracked business. Top customers include:
• PPS INTERNATIONAL CO — $27.1K across 4 shipments (52.0% of this supplier's total exports)
• NUTRI-PHARMA USA COMPANY LIMITED — $25.0K across 3 shipments (48.0% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED operates with high shipment frequency (7 shipments) at a per-shipment value of $7.4K, indicating a broad distribution network with many smaller, regular orders.
6GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED
GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED is the fifth-largest Roxithromycin exporter from India, with a market share of 0.1% and a total export value of $5.9K across 12 shipments. Their average shipment value of $495 is below the market average of $9.8K, reflecting a high-volume, competitive pricing strategy.
GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED serves 3 named buyers in our database. OPHAM -ROUTE DIGUE A is the dominant customer, accounting for 92.7% of this supplier's tracked business. Top customers include:
• OPHAM -ROUTE DIGUE A — $5.5K across 11 shipments (92.7% of this supplier's total exports)
• GOLDEN SPIRIT TRADIN — $319 across 1 shipments (5.4% of this supplier's total exports)
• NOUVELLE PSP COTE D — $111 across 0 shipments (1.9% of this supplier's total exports)
Key Insight: GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED operates with high shipment frequency (12 shipments) at a per-shipment value of $495, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Roxithromycin Flows
Once Roxithromycin leaves the manufacturing plants of companies like BRAWN LABORATORIES LIMITED and STRIDES PHARMA SCIENCE LIMITED, it travels to 5 destination markets with a combined import value of $4.2M. Vietnam absorbs the largest share at 33.9% ($1.4M), followed by Cambodia (18.3%) and Australia (18.2%).
In Vietnam — the top destination — named importers include MILITARY COMMERICAL JOINT STOCK BANK, CAMEL INTERNATIONAL IM-EXPORT, NUTRI-PHARMA USA COMPANY LIMITED. In Cambodia, key buyers are ISKP PHARMA CO., LTD.
This geographic spread reflects Roxithromycin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Roxithromycin Go? Top Importing Countries & Their Buyers
Trade flow of Roxithromycin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Vietnam
Vietnam ranks as the first-largest destination for Roxithromycin imports from India, with a total trade value of $1.4M across 10 shipments — representing a 33.9% share of all Roxithromycin exports. The average shipment value of $141.3K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Roxithromycin importers in Vietnam: MILITARY COMMERICAL JOINT STOCK BANK is the largest buyer, accounting for 41.8% ($590.8K) of this market's total imports.
• MILITARY COMMERICAL JOINT STOCK BANK — $590.8K (41.8% of Vietnam's total)
• CAMEL INTERNATIONAL IM-EXPORT — $93.2K (6.6% of Vietnam's total)
• NUTRI-PHARMA USA COMPANY LIMITED — $83.1K (5.9% of Vietnam's total)
Key Insight: Vietnam's per-shipment average of $141.3K (1346% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Vietnam is a key market for Roxithromycin imports from India.
2Cambodia
Cambodia ranks as the second-largest destination for Roxithromycin imports from India, with a total trade value of $763.2K across 4 shipments — representing a 18.3% share of all Roxithromycin exports. The average shipment value of $190.8K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Roxithromycin importers in Cambodia: ISKP PHARMA CO., LTD is the largest buyer, accounting for 21.6% ($164.8K) of this market's total imports.
• ISKP PHARMA CO., LTD — $164.8K (21.6% of Cambodia's total)
Key Insight: Cambodia's per-shipment average of $190.8K (1852% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Cambodia is a key market for Roxithromycin imports from India.
3Australia
Australia ranks as the third-largest destination for Roxithromycin imports from India, with a total trade value of $758.8K across 45 shipments — representing a 18.2% share of all Roxithromycin exports. The average shipment value of $16.9K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 6 tracked buyers.
Named Roxithromycin importers in Australia: APOTEX PTY LTD., is the largest buyer, accounting for 24.1% ($182.5K) of this market's total imports.
• APOTEX PTY LTD., — $182.5K (24.1% of Australia's total)
• ARROW PHARMACEUTICALS PTY LTD, — $150.2K (19.8% of Australia's total)
• ARROW PHARMACEUTICALS PTY LTD., — $112.2K (14.8% of Australia's total)
Key Insight: Australia's per-shipment average of $16.9K (73% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Roxithromycin imports from India.
4New Zealand
New Zealand ranks as the fourth-largest destination for Roxithromycin imports from India, with a total trade value of $405.4K across 10 shipments — representing a 9.7% share of all Roxithromycin exports. The average shipment value of $40.5K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Roxithromycin importers in New Zealand: TEVA PHARMA (NEW ZEALAND) LIMITED is the largest buyer, accounting for 58.0% ($235.2K) of this market's total imports.
• TEVA PHARMA (NEW ZEALAND) LIMITED — $235.2K (58.0% of New Zealand's total)
• TEVA PHARMA NEW ZEALAND LIMITED — $170.2K (42.0% of New Zealand's total)
Key Insight: New Zealand's per-shipment average of $40.5K (315% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
New Zealand is a key market for Roxithromycin imports from India.
5Myanmar
Myanmar ranks as the fifth-largest destination for Roxithromycin imports from India, with a total trade value of $233.2K across 0 shipments — representing a 5.6% share of all Roxithromycin exports. The average shipment value of $233.2K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations.
Key Insight: Myanmar's per-shipment average of $233.2K (2286% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Myanmar is a key market for Roxithromycin imports from India.
People Also Ask — Roxithromycin Supplier & Trade Network
Who are the top suppliers of Roxithromycin from India?+
Which companies buy Roxithromycin from Indian manufacturers?+
Where does Roxithromycin exported from India go?+
What is the market share of the top Roxithromycin supplier from India?+
What is the average shipment value for Roxithromycin exports from India?+
Is Roxithromycin manufactured in India and exported globally?+
Which country imports the most Roxithromycin from India?+
Who are the buyers of Roxithromycin in Cambodia?+
How concentrated is the Roxithromycin supplier market in India?+
How do I find verified buyers for Roxithromycin in specific countries?+
Roxithromycin Trade Network — Key Takeaways
- 1BRAWN LABORATORIES LIMITED is India's dominant Roxithromycin exporter with a 26.3% market share and $1.1M in total exports — making it the single most important sourcing entity in this market.
- 2The top 78 suppliers collectively account for 52.6% of all tracked Roxithromycin exports, with a combined trade value of $4.2M.
- 3Vietnam is the largest destination market, absorbing 33.9% of India's Roxithromycin exports ($1.4M). Cambodia (18.3%) and Australia (18.2%) follow.
- 4With 427 total shipments averaging $9.8K each, the Roxithromycin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MILITARY COMMERICAL JOINT STOCK BANK, MILITARY COMMERICAL JOINT STOCK BANK, ARROW PHARMACEUTICALS PTY LTD, APOTEX PTY LTD., — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 30 countries
Network value: $4.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Roxithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Roxithromycin.
- 2.Flow Mapping: 78 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 427 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 30 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
427 Verified Shipments
78 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists